News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
BEN-MAIMON CAROLE
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/18/2023 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns:
| Bought 5,000 shares
@ $3.705, valued at
$18.5k
|
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/19/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns:
| Bought 31,746 shares
@ $3.15, valued at
$100k
|
|
05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/20/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns:
| Granted 182,000 options to buy
@ $8.75, valued at
$1.6M
|
|
07/22/2021 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/05/2020 |
3
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 3 on Larimar Therapeutics, Inc. |
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.
Txns:
| Granted 15,385 options to buy
@ $0.65, valued at
$10k
|
|
05/31/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.
Txns:
| Bought 10,000 shares
@ $0.5885, valued at
$5.9k
|
|
05/15/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.
Txns:
| Granted 10,901 options to buy
@ $0.86, valued at
$9.4k
Granted 11,628 options to buy
@ $0.86, valued at
$10k
|
|
01/04/2019 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.
Txns:
| Granted 20,000 options
@ $1.32, valued at
$26.4k
|
|
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/13/2017 |
4
| BEN-MAIMON CAROLE (Director) has filed a Form 4 on Teligent, Inc.
Txns:
| Bought 1,400 shares
@ $3.4784, valued at
$4.9k
Bought 3,600 shares
@ $3.483, valued at
$12.5k
|
|
01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/31/2016 |
3
| BEN-MAIMON CAROLE (Director) has filed a Form 3 on Teligent, Inc. |
10/28/2013 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC
Txns:
| Exercised 6,734 options to buy
@ $18.93, valued at
$127.5k
|
|
10/15/2013 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC
Txns:
| Exercised 5,282 options to buy
@ $18.93, valued at
$100k
|
|
05/28/2013 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC
Txns:
| Paid exercise price by delivering 399 shares
@ $18.6, valued at
$7.4k
|
|
10/29/2012 |
4
| BEN-MAIMON CAROLE (President, Global Pharm.) has filed a Form 4 on IMPAX LABORATORIES INC
Txns:
| Paid exercise price by delivering 1,836 shares
@ $24.34, valued at
$44.7k
|
|
05/25/2012 |
4
| BEN-MAIMON CAROLE (President, Global Pharm. Div.) has filed a Form 4 on IMPAX LABORATORIES INC
Txns:
| Granted 4,333 shares
@ $0 Granted 10,833 options to buy
@ $20.9, valued at
$226.4k
|
|
11/01/2011 |
4
| BEN-MAIMON CAROLE (President, Global Pharm. Div.) has filed a Form 4 on IMPAX LABORATORIES INC
Txns:
| Granted 24,000 shares
@ $0 Granted 75,000 options to buy
@ $18.93, valued at
$1.4M
|
|
09/13/2011 |
3
| BEN-MAIMON CAROLE (President, Global Pharm. Div.) has filed a Form 3 on IMPAX LABORATORIES INC |
|
|